|
Landiolol Impurity 49
|
蘭地洛爾雜質(zhì)49
|
2414593-71-6
|
|
Isosulfan blue Impurity 1
|
異硫藍(lán)雜質(zhì)1
|
|
|
Tadalafil Impurity 73
|
他達(dá)那非雜質(zhì)73
|
|
|
Pranoprofen Impurity D
|
普拉洛芬雜質(zhì)D
|
|
|
Atorvastatin mixture of impurities (impurities E and H)Atorvastatin impurity mixture Batch 2 (EP Y0002310)
|
阿托伐他汀雜質(zhì)混合物(雜質(zhì)E和H）第2批阿托伐他汀雜質(zhì)混合物(EP Y0002310)
|
|
|
Phenytoin Impurity 5
|
苯妥英雜質(zhì)5
|
|
|
Raffinazine impurity 48
|
雷芬那辛雜質(zhì)48
|
|
|
Deglutathin impurity 11
|
德谷胰島素雜質(zhì)11
|
|
|
Danbibiofo stem sitabil tyCRS Y0002351
|
柔紅霉素系統(tǒng)適用性指定貨號Y0002351
|
|
|
Spironolactone EP Impurity D
|
螺內(nèi)酯(安體舒通)EP雜質(zhì)D
|
|
|
Daunorubicin impurity 9
|
柔紅霉素雜質(zhì)9
|
|
|
Pranoprofen Impurity 20
|
普拉洛芬雜質(zhì)20
|
|
|
Dapoxetine Impurity 65
|
達(dá)泊西汀雜質(zhì)65
|
|
|
Minoxidil Impurity 9
|
米諾地爾雜質(zhì)9
|
79459-04-4
|
|
Nicorandil Impurity 53
|
尼可地爾雜質(zhì)53
|
|
|
Metoclopramide Impurity 35
|
甲氧氯普胺雜質(zhì)35
|
|
|
Rapamycin Impurity 24
|
雷帕霉素雜質(zhì)24
|
|
|
Deglutathin impurity 8
|
德谷胰島素雜質(zhì)8
|
|
|
Minoxidil Impurity 44
|
米諾地爾雜質(zhì)44
|
|
|
Mometasone Furoate Impurity 5
|
糠酸莫米松雜質(zhì)5
|
|
|
Gadobutrol impurity 7
|
釓布醇雜質(zhì)7
|
|
|
Phenytoin Impurity 4
|
苯妥英雜質(zhì)4
|
56079-91-5
|
|
Calcitriol Impurity 32
|
骨化三醇雜質(zhì)32
|
87649-60-3
|
|
Nicorandil Impurity 49
|
尼可地爾雜質(zhì)49
|
|
|
Metoclopramide Impurity 29
|
甲氧氯普胺雜質(zhì)29
|
1829835-87-1
|
|
Benzathine penicillin impurity 4
|
芐星青霉素雜質(zhì)4
|
|
|
N-Nitroso desmethoxy impurity 1
|
N-亞硝基脫甲氧基雜質(zhì)1
|
|
|
Bumetanide Impurity 38
|
布美他尼雜質(zhì)38
|
|
|
Propafenone Impurity 56
|
普羅帕酮雜質(zhì)56
|
|
|
Sitagliptin Impurity 73
|
西格列汀雜質(zhì)73
|
|
|
Pranoprofen Impurity 4
|
普拉洛芬雜質(zhì)4
|
|
|
Amphotericin B Impurity 14
|
兩性霉素B雜質(zhì)14
|
1561-07-5
|
|
Amisulpride Impurity 12
|
氨磺必利雜質(zhì)12
|
82689-92-7
|
|
Eltrombopag Impurity 53
|
艾曲波帕雜質(zhì)53
|
|
|
Atorvastatin for the identification of impurity B (similar impurity D1 and D2)Atorvastatin for peak identification B Batch 1(EP Y0002304)
|
阿托伐他汀用于鑒別雜質(zhì)B（類似雜質(zhì)D1和D2)用于峰識別的阿托伐他汀B批次1(EP Y0002304)
|
|
|
Landiolol Impurity 50
|
蘭地洛爾雜質(zhì)50
|
|
|
Metformin hydrochloride Impurity F (EP Y0001600)
|
鹽酸二甲雙胍雜質(zhì)F（EP Y0001600）
|
|
|
Deglutathin impurity 12
|
德谷胰島素雜質(zhì)12
|
|
|
Amlodipine Impurity 86
|
氨氯地平雜質(zhì)86
|
|
|
Phenytoin Impurity 3
|
苯妥英雜質(zhì)3
|
69489-37-8
|
|
Spironolactone EP Impurity I
|
螺內(nèi)酯(安體舒通)EP雜質(zhì)I
|
|
|
Prucalopride Impurity 2
|
普卡必利雜質(zhì)2
|
1900715-96-9
|
|
Escitalopram Impurity 32
|
艾司西酞普蘭雜質(zhì)32
|
|
|
Exemestane EP Impurity I
|
依西美坦EP雜質(zhì)I
|
|
|
Tranexamic acid (impurity) C（USP 1672756)
|
氨甲環(huán)酸（雜質(zhì)）C（USP 1672756）
|
|
|
5-(4-hydroxyphenyl)-1-phenylpentan-1-one
|
5-(4-羥基苯基)-1-苯基戊-1-酮
|
|
|
Raffinazine impurity 46
|
雷芬那辛雜質(zhì)46
|
|
|
Deglutathin impurity 9
|
德谷胰島素雜質(zhì)9
|
|
|
Daunorubicin hydrochloride impurity 3
|
鹽酸柔紅霉素雜質(zhì)3
|
|
|
Torasemi impurity 9
|
托拉塞米雜質(zhì)9
|
|
|
Calcitriol Impurity 33
|
骨化三醇雜質(zhì)33
|
87649-61-4
|
|
Nicorandil Impurity 50
|
尼可地爾雜質(zhì)50
|
|
|
Human Collagen Type III (sigma CC054)
|
人膠原III型(sigma CC054)
|
|
|
Benzathine penicillin impurity 5
|
芐星青霉素雜質(zhì)5
|
|
|
Deglutathin impurity 6
|
德谷胰島素雜質(zhì)6
|
|
|
Bumetanide Impurity 39
|
布美他尼雜質(zhì)39
|
|
|
Teprenone impurity 38
|
替普瑞酮雜質(zhì)38
|
|
|
Perindopril Impurity 4
|
培哚普利雜質(zhì)4
|
|
|
Tenofovir Impurity 60
|
替諾福韋雜質(zhì)60
|
|
|
Metoclopramide Impurity 36
|
甲氧氯普胺雜質(zhì)36
|
|
|
Atorvastatin for identification of impurity A (similar impurity A,B,F,G)Atorvastatin for peak identification A Batch 1(EP Y0002319)
|
用于鑒別雜質(zhì)A的阿托伐他汀（類似雜質(zhì)A、B、F、G）峰識別的阿托伐他汀A批次1(EP Y0002319)
|
|
|
Diacerein Impurity 5
|
雙醋瑞因雜質(zhì)5
|
|
|
Vacacylovir related substance C (USP 1707855)
|
伐昔洛韋有關(guān)物質(zhì)C(USP 1707855)
|
|
|
Deglutathin impurity 13
|
德谷胰島素雜質(zhì)13
|
|
|
Rapamycin Impurity 47
|
雷帕霉素雜質(zhì)47
|
|
|
Ibandronate sodium impurity 1
|
伊班膦酸鈉雜質(zhì)1
|
919491-64-8
|
|
Oxybuprocaine Impurity 1
|
奧布卡因雜質(zhì)1
|
|
|
Topiroxostat Impurity 10
|
托匹司他雜質(zhì)10
|
|
|
penicillin impurity 5
|
青霉素雜質(zhì)5
|
4052-54-4
|
|
SanLeng diphenyllactone
|
三棱雙苯內(nèi)酯
|
1082546-38-0
|
|
CO Carbinoxamine impurity C Carbinoxamine Related Compound C(N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate)(USP 1096032)
|
CO碳胺雜質(zhì)C碳胺相關(guān)化合物C（N，N-二甲基-2-[苯基（吡啶-2-基）甲氧基]乙烷-1-胺草酸乙酯）(USP 1096032)
|
|
|
Calcitriol Impurity 42
|
骨化三醇雜質(zhì)42
|
|
|
Raffinazine impurity 47
|
雷芬那辛雜質(zhì)47
|
|
|
Deglutathin impurity 10
|
德谷胰島素雜質(zhì)10
|
|
|
Daunorubicin impurity 10
|
柔紅霉素雜質(zhì)10
|
|
|
Spironolactone EP Impurity B
|
螺內(nèi)酯(安體舒通)EP雜質(zhì)B
|
|
|
Dapoxetine Impurity 66
|
達(dá)泊西汀雜質(zhì)66
|
|
|
Levocarnitine Impurity 15
|
左卡尼汀雜質(zhì)15
|
931426-07-2
|
|
Nicorandil Impurity 52
|
尼可地爾雜質(zhì)52
|
|
|
Tiprazone Impurities Control (TLCT-T-111013)
|
替普瑞酮雜質(zhì)對照品(TLC T-T-111013)
|
|
|
Amphotericin B Impurity 15
|
兩性霉素B雜質(zhì)15
|
|
|
Deglutathin impurity 7
|
德谷胰島素雜質(zhì)7
|
|
|
Beraprost impurity 25
|
貝前列素雜質(zhì)25
|
|
|
5-(γ-FOLINOYL)TETRAHYDROFOLATE
|
5-(γ-葉酸基)四氫葉酸
|
|
|
Dapoxetine Impurity 53
|
達(dá)泊西汀雜質(zhì)53
|
|
|
alfacalcidol for system suitability A CRS
|
阿法骨化醇用于系統(tǒng)適用性A CRS(指定品牌:EP貨號:Y0002125)
|
|
|
Mometasone Furoate Impurity 4
|
糠酸莫米松雜質(zhì)4
|
|
|
Calcitriol Impurity 28
|
骨化三醇雜質(zhì)28
|
67869-32-3
|
|
Escitalopram Impurity 33
|
艾司西酞普蘭雜質(zhì)33
|
|
|
Gramicidin (standard) standard category（EP G0550000）
|
革蘭氏菌素（標(biāo)準(zhǔn)）標(biāo)準(zhǔn)類別（EP G0550000）
|
|
|
Tadalafil Impurity 74
|
他達(dá)那非雜質(zhì)74
|
|
|
penicillin impurity 4
|
青霉素雜質(zhì)4
|
|
|
N-Nitroso N-oxide
|
N-亞硝基氧化物
|
|
|
Tetracaine Impurity 25
|
丁卡因雜質(zhì)25
|
|
|
Minoxidil Impurity 45
|
米諾地爾雜質(zhì)45
|
|
|
Tryptophan Impurity 12
|
色氨酸雜質(zhì)12
|
56777-76-5
|
|
Etoposide Impurity 5
|
依托泊苷雜質(zhì)5
|
|
|
Gadobutrol impurity 10
|
釓布醇雜質(zhì)10
|
|
|
Torasemi impurity 8
|
托拉塞米雜質(zhì)8
|
|
|
alfacalcidol impurity B CRS
|
阿法骨化醇雜質(zhì)B CRS(指定品牌:EP，貨號:Y0002296)
|
|